Lung dopaminergic nerves facilitate the establishment of T<sub>H</sub>2 resident memory cells in early life.

Wang, Wei; Garcia, Carolyn; Shao, Fengzhi; Cohen, Jonathan A; Bai, Yan; Fine, Alan; Ai, Xingbin · J Allergy Clin Immunol · 2023

basic_science · Level V

Where this comes from

Abstract

Allergic asthma develops from allergen exposure in early childhood and progresses into adulthood. The central mediator of progressive allergic asthma is allergen-specific, T<sub>H</sub>2-resident memory cells (TRMs). Although the crosstalk between nerves and immune cells plays an established role in acute allergic inflammation, whether nerves facilitate the establishment of T<sub>H</sub>2-TRMs in the immature lung following early life allergen exposure is unknown. The aim of this study was to identify nerve-derived signals that act in T<sub>H</sub>2 effector cells to regulate the tissue residency in the immature lung. Following neonatal allergen exposure, allergen-specific T<sub>H</sub>2-TRMs were tracked temporally and spatially in relationship to developing sympathetic nerves in the lung. Functional mediators of dopamine signaling in the establishment of T<sub>H</sub>2-TRMs were identified by in vitro bulk RNA-sequencing of dopamine-treated T<sub>H</sub>2 cells followed by in vivo assessment of candidate genes using adoptive transfer of T<sub>H</sub>2 cells with viral gene knockdown. This study found that sympathetic nerves produce dopamine and reside in proximity to T<sub>H</sub>2 effector cells during the contraction phase following neonatal allergen exposure. Dopamine signals via DRD4 on T<sub>H</sub>2 cells to elevate IL2RA and epigenetically facilitate type 2 cytokine expression. Blockade of dopamine-DRD4 signaling following neonatal allergen exposure impairs lung residence of T<sub>H</sub>2 cells and ameliorates anamnestic inflammation in adults. These results demonstrate that maturing sympathetic nerves enable a dopamine-enriched lung environment in early life that promotes the establishment of allergen-specific T<sub>H</sub>2-TRMs. The dopamine-DRD4 axis may provide a therapeutic target to modify allergic asthma progression from childhood to adulthood.

Medical subject headings